Toggle light / dark theme

A large research team led by nanotechnologist Roy van der Meel rebuilt the body’s own proteins and fats into nano-delivery vans that get genetic medicines to exactly the right place in the body. In a joint effort with researchers from Radboudumc, they worked for five years on this nanotransport system, the results of which were published in Nature Nanotechnology.

With his rugged beard and signature lumberjack shirt, nanotechnologist Roy van der Meel seems to have walked straight out of a Canadian forest hut instead of a high-tech lab. In Canada, Van der Meel did indeed work as a postdoc for Professor Pieter Cullis, founder of the nanotechnology used for messenger RNA vaccines. Five years ago, he exchanged Vancouver for a spot in Eindhoven. Professor Willem Mulder brought Van der Meel to TU/e because of his RNA nanotechnology expertise.

Diseases that are currently difficult to cure, such as certain cancers and , can benefit from genetic drugs based on RNA. But then we must be able to get those medicines to the right place and that turns out to be a huge task.

As long as you have problems posting, I would recommend using a “throwaway” account to do your posting so you never lose your main account. A few months ago, I actually got 2 of my “throwaway” accounts UNBANNED. It is cool when you end up gaining accounts instead of losing them.

S timeline but they almost never complain recently.


The weekend release of the US Central Intelligence Agency (CIA) report favouring a laboratory leak as the likely origin of COVID-19 – albeit with “low confidence” – has reignited a vitriolic debate.

On the one side of the divide are those who argue that SARS-CoV2, the virus causing COVID-19, originated from a lab leak from the Wuhan Institute of Virology (WIV) that was studying coronaviruses in bats.

Some researchers who favour the lab-leak thesis argue that the virus contains unusual features that indicate it may have been genetically modified by humans. These focus on the virus’s furin cleavage site, a strange feature on the spike protein of the virus that is not present in other coronaviruses, that cast doubt on whether the virus had evolved naturally.

Dive into the captivating realm of Biopunk Science Fiction in our latest video! 🌱 Discover what Biopunk is, from genetic engineering to human augmentation, and explore the ethical dilemmas it presents in our modern world. We’ll discuss its evolution through literature and film, touching on iconic works like \.

Biopunk androids replicants.


What happens when humans begin combining biology with technology, harnessing the power to recode life itself.

What does the future of biotechnology and genetic engineering look like? How will humans program biology to create organ farm technology and bio-robots. And what happens when companies begin investing in advanced bio-printing, artificial wombs, and cybernetic prosthetic limbs.

Other topic include: bioengineered food and farming, bio-printing in space, new age living bioarchitecture (eco concrete inspired by coral reefs), bioengineered bioluminescence, cyberpunks and biopunks who experiment underground — creating new age food and pets, the future of bionics, corporations owning bionic limbs, the multi-trillion dollar industry of bio-robots, and bioengineered humans with super powers (Neo-Humans).

As well as the future of biomedical engineering, biochemistry, and biodiversity.

“ tabindex=”0” amino acids and incorporated sulfur-based compounds much earlier than previously thought. This challenges long-standing experiments and opens the door to the possibility that extinct genetic codes existed before ours.

Cracking the Code of Life’s Origins

Despite awe-inspiring diversity, nearly all life on Earth — from tiny bacteria to massive blue whales — shares the same genetic code. But exactly how and when this code emerged remains a topic of scientific debate.

A study reveals DNA

DNA, or deoxyribonucleic acid, is a molecule composed of two long strands of nucleotides that coil around each other to form a double helix. It is the hereditary material in humans and almost all other organisms that carries genetic instructions for development, functioning, growth, and reproduction. Nearly every cell in a person’s body has the same DNA. Most DNA is located in the cell nucleus (where it is called nuclear DNA), but a small amount of DNA can also be found in the mitochondria (where it is called mitochondrial DNA or mtDNA).

Researchers have uncovered a way to manipulate DNA

DNA, or deoxyribonucleic acid, is a molecule composed of two long strands of nucleotides that coil around each other to form a double helix. It is the hereditary material in humans and almost all other organisms that carries genetic instructions for development, functioning, growth, and reproduction. Nearly every cell in a person’s body has the same DNA. Most DNA is located in the cell nucleus (where it is called nuclear DNA), but a small amount of DNA can also be found in the mitochondria (where it is called mitochondrial DNA or mtDNA).

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links/Affiliates:
Blood testing (where I get the majority of my labs): https://www.ultalabtests.com/partners/michaellustgarten.

At-Home Metabolomics: https://www.iollo.com?ref=michael-lustgarten.
Use Code: CONQUERAGING At Checkout.

Clearly Filtered Water Filter: https://get.aspr.app/SHoPY

Epigenetic, Telomere Testing: https://trudiagnostic.com/?irclickid=U-s3Ii2r7xyIU-LSYLyQdQ6…M0&irgwc=1
Use Code: CONQUERAGING

NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/

Panzeri et al. use a Trim28 +/D9 mouse model with intrinsic developmental heterogeneity to show that ‘heavy’ and ‘light’ developmental morphs exhibit different timing, type and severity of cancer, linked to a relevant DNA hypomethylation signature.

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice. Their work establishes a next-generation gene-editing tool that enhances genetic manipulation for cancer and medical research in a preclinical model.

The study, “Advancing the genetic engineering toolbox by combining AsCas12a knock-in mice with ultra-compact screening,” was published in Nature Communications.

“This is the first time Cas12a has been used in preclinical models, which will greatly advance our genome engineering capabilities,” said co-author Eddie La Marca, PhD, a postdoctoral researcher at the Olivia Newton-John Cancer Research Institute (ONJCRI) in Australia.